Results 151 to 160 of about 170,221 (359)

Predictive Flux Control for Induction Motor Drives With Modified Disturbance Observer for Improved Transient Response [PDF]

, 2020
Muhammad Abbas Abbasi, Abdul Rashid Husain, Nik Rumzi Nik Idris, Waqas Anjum, Hussain Bassi, Muhyaddin Rawa   +5 more
openalex   +1 more source

Patient‐specific pharmacogenomics demonstrates xCT as predictive therapeutic target in colon cancer with possible implications in tumor connectivity

Molecular Oncology, EarlyView.
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker, Keren Zohar, Martin Böttcher, Thomas Wartmann, Henry Freudenstein, Maximilian Doelling, Mihailo Andric, Wenjie Shi, Or Kakhlon, Katrin Hippe, Beatrix Jahnke, Dimitrios Mougiakakos, Franziska Baenke, Daniel Stange, Roland S. Croner, Michal Linial, Ulf D. Kahlert   +16 more
wiley   +1 more source

Zero-Airgap Induction Motor Used to Drive a Transmission Oil Pump [PDF]

, 2020
Dan-Cristian Popa, Florin Nicolae Jurca, Răzvan Alexandru Ințe, Nicholas Hrusch, Jeff Hemphill, Codrin G. Cantemir   +5 more
openalex   +1 more source

Predictors of response and rational combinations for the novel MCL‐1 inhibitor MIK665 in acute myeloid leukemia

Molecular Oncology, EarlyView.
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad, Rhiannon Newman, Elmira Khabusheva, Sofia Aakko, Eric Durand, Mahesh Tambe, Heikki Kuusanmäki, Alun Parsons, Juho J. Miettinen, Komal Kumar Javarappa, Ezgi June Olgac, Nemo Ikonen, Mika Kontro, Kimmo Porkka, Heiko Maacke, Janghee Woo, Ensar Halilovic, Caroline A. Heckman   +17 more
wiley   +1 more source

Experimental comparison of induction and synchronous reluctance electric drive performance [PDF]

, 2015
Работа имеет целью экспериментальное сравнение конструктивных и энергетических характеристик современных асинхронных двигателей (АД) отечественного и зарубежного производства (ABB) и разработанного авторами синхронного реактивного двигателя (СРД) в ...
Dmitrievskii, V. A., Kazakbaev, V. V., Mikhalitsyn, A. F., Oshurbekov, S. H., Pozdeev, A. S., Prakht, V. A., Дмитриевский, В. А., Казакбаев, В. М., Михалицын, А. Ф., Ошурбеков, С. Х., Поздеев, А. С., Прахт, В. А.   +11 more
core  

Hardware-in-the-loop based comparative analysis of speed controllers for a two-mass system using an induction motor drive with ideal stator current performance

, 2021
Võ Thanh Hà, Tùng Lâm Nguyễn, Vo Thu Hà   +2 more
openalex   +2 more sources

Stator Inductance Identification Based on Low-Speed Tests for Three-Level NPC Inverter-Fed Induction Motor Drives [PDF]

, 2020
Yerganat Khojakhan, Kyoung-Min Choo, Chung-Yuen Won   +2 more
openalex   +1 more source

Flux-Weakening Control of Linear Induction Motor Drives Considering the Primary Resistance and End Effect [PDF]

, 2022
Pegah Hamedani
openalex   +1 more source

Aggressive prostate cancer is associated with pericyte dysfunction

Molecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero, Ane Martinez‐Larrinaga, Joaquim Grego‐Bessa, Saioa Garcia‐Longarte, Hielke van Splunder, Ianire Astobiza, Amaia Ercilla, Laura Bozal‐Basterra, Isabel Mendizabal, Pilar Villacampa, Arkaitz Carracedo, Mariona Graupera   +11 more
wiley   +1 more source

Plasma extrachromosomal circular DNA as a biomarker in EGFR‐targeted therapy of non‐small cell lung cancer

Molecular Oncology, EarlyView.
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard, Sarmad Mehmood, Eva Boysen Fynboe Ebert, Peter Meldgaard, Anindya Dutta, Boe S. Sorensen   +5 more
wiley   +1 more source